Skip to main content
. 2017 Nov 7;4:67. doi: 10.3389/fcvm.2017.00067

Table 1.

Summary of pro-thrombotic elements observed in cancer.

Mediator Origin Mechanism
Tissue factor (TF)
  • Platelets

  • Malignant cell expressed

  • Malignant cell secreted microparticles

  • Activates platelets

  • Activates extrinsic clotting cascade

  • Binds with Factor Vll/Vlla and this complex activates Factor IX to IXa and Factor X to Xa

  • Ultimately increases activation of prothrombin to thrombin

Matrix metaloprotease
  • Native cell secreted

  • Malignant cell secreted

  • Activates platelets independent of TF

  • Increases platelet binding to fibrinogen increases platelet aggregation

Vascular endothelial growth factor (VEGF)
  • Native cell secreted

  • Malignant cell secreted

  • Increases VonWillebrand Factor expression on endothelial cells, promoting platelet aggregation

  • Increases endothelial permeability, exposing cells and clotting factors to extravascular TF

  • Draws pro-inflammatory leukocytes, which complex with platelets and form microthrombi

Cancer Procoagulant
  • Malignant cells only

  • Activates FX to FXa independent of TF

Heparanase
  • Platelets

  • Neutrophils

  • Monocytes

  • Malignant cell cytoplasm malignant cell secreted

  • Enhances TF activity

  • Activates VEGF, increases neoangiogenesis